[ad_1] Senate Finance Chair Ron Wyden (D-Ore.) said he hoped Democrats could still find a way to address rising prescription drug costs but acknowledged the power the industry has shown so far to prevent even modest changes. “Pharma is everywhere,” he told reporters Thursday. “They have got more lobbyists than anybody.” The Pharmaceutical Research and
drug
[ad_1] The pressure to reach an agreement that can pass the House and Senate has intensified with the failure to reach agreements on other revenue-raising provisions that can pay for new programs in the bill, including expansions of Medicare, Medicaid, Obamacare subsidies and home health care. Efforts to raise taxes on the wealthy and corporations,
[ad_1] Excessively high prescription drug prices are a substantial financial burden on Americans like Louise and her husband, but they also raise insurance premiums and taxes for you and me by increasing costs for insurance companies, Medicare and Medicaid. Society will pay the other $200,000 through those higher premiums and taxes. Tafamidis is not the
[ad_1] The Cannabis Administration and Opportunity Act (CAOA) is the most comprehensive piece of cannabis reform legislation ever introduced in Congress. It takes seriously the numerous questions left open in previous legislative proposals, including the twice-House-passed MORE Act. The bill’s primary sponsors, Sens. Booker (D-NJ); Wyden (D-OR); and Schumer (D-NY), placed racial justice at the